Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

被引:98
|
作者
Washington, K
Wright, K
Shyr, Y
Hunter, EB
Olson, S
Raiford, DS
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA
关键词
nonalcoholic steatohepatitis; fibrosis; steatosis; hepatic stellate cell;
D O I
10.1053/hupa.2000.8440
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Factors associated with the development of fibrosis in nonalcoholic steatohepatitis (NASH) are largely unknown, although an association with increased hepatic iron has been suggested. Hepatic stellate cells are the principal collagen-producing cells in many liver diseases and when activated express alpha-smooth muscle actin (alpha-SMA). Hepatic stellate cell activation and association with fibrosis, necroinflammatory activity steatosis, and stainable iron in 60 cases of NASH and 16 cases of steatosis were evaluated. All 76 patients were obese or had other risk factors for NASH. All biopsy specimens were stained for alpha-smooth muscle actin to evaluate the pattern of hepatic stellate cell activation and were evaluated for inflammatory activity (0 to 3), fibrosis (0 to 4), and stainable iron stores (0 to 4). The zonal location of activated stellate cells was recorded, and the degree of activation was graded as high-grade or low-grade based on the percentage of lobular alpha-SMA+ cells. Activated stellate cells were identified in the hepatic lobule in 74 of 76 biopsy specimens and graded as low-grade in 26 and high-grade in 48. Zone 3 was involved in 72 of 74 positive cases, and in 33 cases, the activated stellate cells were preferentially located in zone 3, The degree of stellate cell activation correlated with fibrosis but not with inflammatory activity, severity of steatosis, or stainable iron. In most cases, the degree of stellate cell activation paralleled the degree of hepatic fibrosis, but in 25 cases, the degree of hepatic stellate cell activation was greater than expected, raising the question of whether such patients are at risk for disease progression. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 50 条
  • [1] Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis
    Cortez-Pinto, H
    Baptista, A
    Camilo, ME
    de Moura, MC
    HEPATO-GASTROENTEROLOGY, 2001, 48 (37) : 87 - 90
  • [2] The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Cha J.-Y.
    Kim D.-H.
    Chun K.-H.
    Laboratory Animal Research, 2018, 34 (4) : 133 - 139
  • [3] Zonal Hepatic Stellate Cell (HSC) Activation in Nonalcoholic Steatohepatitis (NASH) Characterized By a Mathematical Model
    Longo, Diane
    Generaux, Grant
    Battista, Christina M.
    Watkins, Paul B.
    Howell, Brett A.
    Siler, Scott Q.
    HEPATOLOGY, 2018, 68 : 625A - 625A
  • [4] Advanced glycosylation endproducts in nonalcoholic steatohepatitis: a second hit that drives hepatic stellate cell activation?
    Leung, Christopher
    Herath, Chandana
    Jia Zhiyuan
    Goodwin, Michelle
    Mak, Kai Yan
    Forbes, Josephine M.
    Angus, Peter
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 9 - 9
  • [5] Hepatic stellate cell activation, hepatic stellate cell and hepatocyte proliferation and apoptosis in liver biopsies from individuals with HCV, steatohepatitis, and HCV steatohepatitis.
    Canchis, PW
    Talal, AH
    Jacobson, IM
    Russo, MW
    Davila, J
    Teixeira, AA
    Chiriboga, L
    Yee, H
    Fiel, MI
    HEPATOLOGY, 2002, 36 (04) : 278A - 278A
  • [6] Hepatic stellate cell activation score predicts fibrosis progression in patients with nonalcoholic fatty liver disease.
    Feldstein, AE
    Papouchado, BG
    Angulo, P
    Sanderson, S
    Adams, L
    Gores, GJ
    HEPATOLOGY, 2004, 40 (04) : 196A - 196A
  • [7] A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease
    Trasino, Steven E.
    Tang, Xiao-Han
    Jessurun, Jose
    Gudas, Lorraine J.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (10): : 1143 - 1151
  • [8] A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease
    Steven E. Trasino
    Xiao-Han Tang
    Jose Jessurun
    Lorraine J. Gudas
    Journal of Molecular Medicine, 2016, 94 : 1143 - 1151
  • [9] NLRP3 INFLAMMASOME ACTIVATION IN NEUTROPHILS DRIVES HEPATIC STELLATE CELL ACTIVATION IN MURINE NONALCOHOLIC STEATOHEPATITIS
    Kaufmann, Benedikt
    Booshehri, Laela
    Leszczynska, Ola
    Friess, Helmut
    Hartmann, Daniel
    Broderick, Lori
    Hoffman, Hal
    Feldstein, Ariel E.
    HEPATOLOGY, 2023, 78 : S1119 - S1119
  • [10] FoxO1 Functions to Suppress Hepatic Stellate Cell Activation and Protect against Nonalcoholic Steatohepatitis
    Chhetri, Goma
    Gao, Jingyang
    Usman, Taofeek
    Zheng, Wen Quan
    Dong, H. Henry
    DIABETES, 2024, 73